These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8279055)

  • 41. Progress toward interruption of wild poliovirus transmission--worldwide, January 2005-March 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(16):458-62. PubMed ID: 16645572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poliomyelitis in the world.
    Cockburn WC; Drozdov SG
    Bull World Health Organ; 1970; 42(3):405-17. PubMed ID: 5310207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Eradication of germs causing epidemics? A critical account].
    Henneberg G
    Wien Med Wochenschr; 1966 Feb; 116(9):175-8. PubMed ID: 5982633
    [No Abstract]   [Full Text] [Related]  

  • 44. Polio eradication, cessation of vaccination and re-emergence of disease.
    Minor PD
    Nat Rev Microbiol; 2004 Jun; 2(6):473-82. PubMed ID: 15152203
    [No Abstract]   [Full Text] [Related]  

  • 45. Principles of vaccination and possible development strategies for rational design.
    Boog CJ
    Immunol Lett; 2009 Feb; 122(2):104-7. PubMed ID: 19100778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The principles and feasibility of disease eradication.
    Dowdle WR; Cochi SL
    Vaccine; 2011 Dec; 29 Suppl 4():D70-3. PubMed ID: 22188936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
    Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress toward global eradication of poliomyelitis, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jun; 46(25):579-84. PubMed ID: 9214568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polio. Health workers scramble to contain African epidemic.
    Roberts L
    Science; 2004 Jul; 305(5680):24-5. PubMed ID: 15232076
    [No Abstract]   [Full Text] [Related]  

  • 52. Progress toward poliomyelitis eradication--Ethiopia, 1997-August 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(38):867-70. PubMed ID: 11032094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(17):369-71. PubMed ID: 12018383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress toward global poliomyelitis eradication, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Apr; 50(16):320-2, 331. PubMed ID: 11465901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poliomyelitis eradication – the review of notifications from the years 2010-2016 sent to National IHR Focal Point.
    Radziszewski F; Janiec J; Henszel Ł; Izdebski R; Polański P
    Przegl Epidemiol; 2017; 71(1):25-32. PubMed ID: 28654739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The certification of smallpox eradication and implications for guinea worm, poliomyelitis, and other diseases: confirming and maintaining a negative.
    Breman JG; Arita I
    Vaccine; 2011 Dec; 29 Suppl 4():D41-8. PubMed ID: 22185832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perspective: determinants of the severity of poliovirus outbreaks in the post eradication era.
    Fine PE; Ritchie S
    Risk Anal; 2006 Dec; 26(6):1533-40. PubMed ID: 17184395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Problems with the oral polio vaccine.
    Bhasin VK
    Nat Med; 2008 Jan; 14(1):9. PubMed ID: 18180708
    [No Abstract]   [Full Text] [Related]  

  • 60. Progress toward poliomyelitis eradication--India, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Mar; 53(11):238-41. PubMed ID: 15041951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.